Evidence map›Paper›PMID 33061533›Full record

ArticlePharmacogenomics and personalized medicine2020

Genetic Testing for

Guang-Dan Zhu, Eric Dawson, Angela Huskey, Ronald J Gordon, Andria L Del Tredici

Open access · goldAbstract read
In one paragraph

Article in Pharmacogenomics and personalized medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. The history and future of pharmacogenetics in Aotearoa/New Zealand.Journal of the Royal Society of New Zealand · 2025
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Guang-Dan ZhuMillennium Health, LLC, San Diego, CA, USA.ORCID 0000-0003-2029-4360
Eric DawsonMillennium Health, LLC, San Diego, CA, USA.
Angela HuskeyMillennium Health, LLC, San Diego, CA, USA.
Ronald J GordonDepartment of Anesthesiology, University of California, UC San Diego School of Medicine, La Jolla, CA, USA.
Andria L Del TrediciMillennium Health, LLC, San Diego, CA, USA.ORCID 0000-0002-9746-7728
Millennium Engineering and Integration (United States) · USUniversity of California San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGenetic variants in the PURPOSE: Using a clinical test, we investigated the frequencies of MATERIALS AND

methodsFive

resultsThe minor allele frequencies of A, K, F

conclusionWhile severe BChE deficiency is rare in the United States, approximately 8% of Americans are at moderate risk of prolonged post-succinylcholine neuromuscular blockade, suggesting that a sizable percentage of patients may benefit from preoperative genetic testing of

Indexed as

BCHEgenotypingpharmacogeneticsprolonged neuromuscular blockadesuccinylcholine

Identifiers

PMID33061533
PMCPMC7533272
OpenAlexW3091022412

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.